Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy

Yuzhu Ma,1,* Daolu Yuwen,2,* Jingwei Chen,1 Bingfeng Zheng,1 Jian Gao,1 Minmin Fan,1 Wenwen Xue,1 Yixuan Wang,1 Wuhao Li,1 Yongqian Shu,3 Qiang Xu,1 Yan Shen1 1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, People’s Republ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ma Y, Yuwen D, Chen J, Zheng B, Gao J, Fan M, Xue W, Wang Y, Li W, Shu Y, Xu Q, Shen Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/ac9b97cdc23c4203be1ddb1ed915c34d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ac9b97cdc23c4203be1ddb1ed915c34d
record_format dspace
spelling oai:doaj.org-article:ac9b97cdc23c4203be1ddb1ed915c34d2021-12-02T04:39:11ZExosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy1178-2013https://doaj.org/article/ac9b97cdc23c4203be1ddb1ed915c34d2019-10-01T00:00:00Zhttps://www.dovepress.com/exosomal-transfer-of-cisplatin-induced-mir-425-3p-confers-cisplatin-re-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yuzhu Ma,1,* Daolu Yuwen,2,* Jingwei Chen,1 Bingfeng Zheng,1 Jian Gao,1 Minmin Fan,1 Wenwen Xue,1 Yixuan Wang,1 Wuhao Li,1 Yongqian Shu,3 Qiang Xu,1 Yan Shen1 1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, People’s Republic of China; 2Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China; 3Department of Clinical Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qiang Xu; Yan ShenState Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Han Kou Road, Nanjing 210093, People’s Republic of ChinaTel/Fax +86 25 8968 7620Email molpharm@163.com; shenyan@nju.edu.cnIntroduction: Exosomes are important mediators of intercellular communication. Previously, we characterized circulating exosomal miR-425-3p as a non-invasive prognostic marker for predicting clinical response to platinum-based chemotherapy in patients with non-small cell lung cancer (NSCLC).Methods: Circulating exosomal miR-425-3p was validated by qRT-PCR in paired serum samples from NSCLC patients during the course of platinum-based chemotherapy. Cell coculture was performed to examine the effects of exosomal miR-425-3p on the sensitivity of recipient A549 cells to cisplatin. Using bioinformatics, ChIP and luciferase reporter assays, the transcription factor essential for miR-425-3p expression was identified. Autophagic activity in the recipient cells was determined by Western blot and fluorescence microscopy.Results: Higher levels of exosomal miR-425-3p were found in serum samples from the patients in tolerance versus those at baseline. An upward trend in the expression of circulating exosomal miR-425-3p was revealed during chemotherapy. Furthermore, the expression of exosomal miR-425-3p could be induced by cisplatin in NSCLC cells. Exosomes isolated from either cisplatin-treated or cisplatin-resistant NSCLC cells conferred chemoresistance to sensitive A549 cells in a miR-425-3p-dependent manner. Cisplatin-induced c-Myc was found to directly bind the miR-425-3p promoter and transactivated its expression. Exosomal miR-425-3p facilitated autophagic activation in the recipient cells by targeting AKT1, eventually leading to chemoresistance.Discussion: Our results suggest that apart from a prognostic marker of treatment response, exosomal miR-425-3p might be a potential dynamic biomarker to tailor cisplatin resistance in NSCLC patients during the treatment and represent a promising therapeutic target for therapy-resistant NSCLC.Keywords: exosomes, miR-425-3p, NSCLC, chemoresistance, platinum-based chemotherapy, autophagy  Ma YYuwen DChen JZheng BGao JFan MXue WWang YLi WShu YXu QShen YDove Medical PressarticleexosomesmiR-425-3pNSCLCchemoresistanceplatinum-based chemotherapyautophagyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 8121-8132 (2019)
institution DOAJ
collection DOAJ
language EN
topic exosomes
miR-425-3p
NSCLC
chemoresistance
platinum-based chemotherapy
autophagy
Medicine (General)
R5-920
spellingShingle exosomes
miR-425-3p
NSCLC
chemoresistance
platinum-based chemotherapy
autophagy
Medicine (General)
R5-920
Ma Y
Yuwen D
Chen J
Zheng B
Gao J
Fan M
Xue W
Wang Y
Li W
Shu Y
Xu Q
Shen Y
Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
description Yuzhu Ma,1,* Daolu Yuwen,2,* Jingwei Chen,1 Bingfeng Zheng,1 Jian Gao,1 Minmin Fan,1 Wenwen Xue,1 Yixuan Wang,1 Wuhao Li,1 Yongqian Shu,3 Qiang Xu,1 Yan Shen1 1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, People’s Republic of China; 2Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, People’s Republic of China; 3Department of Clinical Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qiang Xu; Yan ShenState Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Han Kou Road, Nanjing 210093, People’s Republic of ChinaTel/Fax +86 25 8968 7620Email molpharm@163.com; shenyan@nju.edu.cnIntroduction: Exosomes are important mediators of intercellular communication. Previously, we characterized circulating exosomal miR-425-3p as a non-invasive prognostic marker for predicting clinical response to platinum-based chemotherapy in patients with non-small cell lung cancer (NSCLC).Methods: Circulating exosomal miR-425-3p was validated by qRT-PCR in paired serum samples from NSCLC patients during the course of platinum-based chemotherapy. Cell coculture was performed to examine the effects of exosomal miR-425-3p on the sensitivity of recipient A549 cells to cisplatin. Using bioinformatics, ChIP and luciferase reporter assays, the transcription factor essential for miR-425-3p expression was identified. Autophagic activity in the recipient cells was determined by Western blot and fluorescence microscopy.Results: Higher levels of exosomal miR-425-3p were found in serum samples from the patients in tolerance versus those at baseline. An upward trend in the expression of circulating exosomal miR-425-3p was revealed during chemotherapy. Furthermore, the expression of exosomal miR-425-3p could be induced by cisplatin in NSCLC cells. Exosomes isolated from either cisplatin-treated or cisplatin-resistant NSCLC cells conferred chemoresistance to sensitive A549 cells in a miR-425-3p-dependent manner. Cisplatin-induced c-Myc was found to directly bind the miR-425-3p promoter and transactivated its expression. Exosomal miR-425-3p facilitated autophagic activation in the recipient cells by targeting AKT1, eventually leading to chemoresistance.Discussion: Our results suggest that apart from a prognostic marker of treatment response, exosomal miR-425-3p might be a potential dynamic biomarker to tailor cisplatin resistance in NSCLC patients during the treatment and represent a promising therapeutic target for therapy-resistant NSCLC.Keywords: exosomes, miR-425-3p, NSCLC, chemoresistance, platinum-based chemotherapy, autophagy  
format article
author Ma Y
Yuwen D
Chen J
Zheng B
Gao J
Fan M
Xue W
Wang Y
Li W
Shu Y
Xu Q
Shen Y
author_facet Ma Y
Yuwen D
Chen J
Zheng B
Gao J
Fan M
Xue W
Wang Y
Li W
Shu Y
Xu Q
Shen Y
author_sort Ma Y
title Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
title_short Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
title_full Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
title_fullStr Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
title_full_unstemmed Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
title_sort exosomal transfer of cisplatin-induced mir-425-3p confers cisplatin resistance in nsclc through activating autophagy
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/ac9b97cdc23c4203be1ddb1ed915c34d
work_keys_str_mv AT may exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT yuwend exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT chenj exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT zhengb exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT gaoj exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT fanm exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT xuew exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT wangy exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT liw exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT shuy exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT xuq exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
AT sheny exosomaltransferofcisplatininducedmir4253pconferscisplatinresistanceinnsclcthroughactivatingautophagy
_version_ 1718401143578558464